Abstract:Many transcription factors play a key role in cellular differentiation and the delineation of cell phenotype. Transcription factors are regulated by phosphorylation, ubiquitination, acetylation/deacetylation and interactions between two or more proteins controlling multiple signaling pathways. These pathways regulate different physiological processes and pathological events, such as cancer and other diseases. The Forkhead box O (FOXO) is one subfamily of the fork head transcription factor family with important roles in cell fate decisions and this subfamily is also suggested to play a pivotal functional role as a tumor suppressor in a wide range of cancers. During apoptosis, FOXOs are involved in mitochondria-dependent and -independent processes triggering the expression of death receptor ligands like Fas ligand, TNF apoptosis ligand and Bcl‑XL, bNIP3, Bim from Bcl-2 family members. Different types of growth factors like insulin play a vital role in the regulation of FOXOs. The most important pathway interacting with FOXO in different types of cancers is the PI3K/AKT pathway. Some other important pathways such as the Ras-MEK-ERK, IKK and AMPK pathways are also associated with FOXOs in tumorigenesis. Therapeutically targeting the FOXO signaling pathway(s) could lead to the discovery and development of efficacious agents against some cancers, but this requires an enhanced understanding and knowledge of FOXO transcription factors and their regulation and functioning. This review focused on the current understanding of cell biology of FOXO transcription factors which relates to their potential role as targets for the treatment and prevention of human cancers. We also discuss drugs which are currently being used for cancer treatment along with their target pathways and also point out some potential drawbacks of those drugs, which further signifies the need for development of new drug strategies in the field of cancer treatment.

The Role of FOXOs and Autophagy in Cancer and Metastasis—implications in Therapeutic Development

The role of FOXOs and autophagy in cancer and metastasis-Implications in therapeutic development

FOXN Transcription Factors: Regulation and Significant Role in Cancer

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

FOXO Signaling Pathways as Therapeutic Targets in Cancer

FOXO transcription factor family in cancer and metastasis

Role of Forkhead Box Class O proteins in cancer progression and metastasis

Mechanisms Controlling the Anti-Neoplastic Functions of FoxO Proteins.

Research Progress in the Relationship Between FOXM1 and Neoplasm Metabolism

Autophagy Regulators As Potential Cancer Therapeutic Agents: A Review

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance

Anti-Neoplastic Activity of the Cytosolic Foxo1 Results from Autophagic Cell Death

The Role of Autophagy in Liver Cancer: Crosstalk in Signaling Pathways and Potential Therapeutic Targets

Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy

Role and regulation of FOXO3a: new insights into breast cancer therapy

Emerging roles of FOXK2 in cancers and metabolic disorders

The Emerging Role of Oxidative Stress in Regulating Autophagy: Applications of Cancer Therapy.

FoxO family members in cancer

Autophagy and the Lysosomal System in Cancer

Insight into the Role of Autophagy in Osteosarcoma and Its Therapeutic Implication.

Autophagy Regulators in Cancer